Concepedia

Yan Wang

YW

Statistics

Publications

1

Citations

21

H-Index

1

Active since

2022

Affiliations

Vertex Pharmaceuticals (United States)(Current)

Yan Wang is an author at Vertex Pharmaceuticals (United States).

ORCID

Publications per year

2022–2022

1

Publications

1

Mavorixafor, an Orally Bioavailable CXCR4 Antagonist, Increases Immune Cell Infiltration and Inflammatory Status of Tumor Microenvironment in Patients with Melanoma

Robert H.I. Andtbacka, Yan Wang, Robert H. Pierce et al. · Cancer Research Communications · 2022 · 21 citations · Full text

1–1 of 1